United Therapeutics buy JPMorgan Chase & Co.
Start price
21.04.25
/
50%
€255.00
Target price
21.04.26
€309.35
Performance (%)
59.69%
Price
17.02.26
€407.20
Summary
This prediction is currently active. With a performance of 59.69% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 21.04.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 2.389% | 2.389% |
| iShares Core DAX® | 0.193% | -1.216% |
| iShares Nasdaq 100 | -1.353% | -5.307% |
| iShares Nikkei 225® | -0.426% | 7.319% |
| iShares S&P 500 | -1.008% | -3.400% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target lowered by analysts at JPMorgan Chase & Co. from $357.00 to $355.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€250.20
08.07.25
08.07.25
€281.09
08.07.26
08.07.26
62.59%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€260.00
01.05.25
01.05.25
€309.54
01.05.26
01.05.26
56.62%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€255.10
21.05.24
21.05.24
€276.33
21.05.25
21.05.25
6.82%
22.05.25
22.05.25